Project Grant HT94252310543
Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $723K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- This $366,419 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research into "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection." The 3-year award period runs from July 1, 2023 to June 30, 2026. The Johns Hopkins University, a private non-profit research university, will conduct this biomedical research to develop innovative solutions for treating...
- The Johns Hopkins University was awarded a $974,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, spanning August 1, 2023 to July 31, 2026, will support research to engineer an effective combination therapy of car T cells and regulatory T cells to control rejection of vascularized composite allografts. This research aims to develop medical solutions for the battlefield and transform healthcare for...
- This $499,957 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by The Johns Hopkins University to investigate extracellular vesicle-mediated PD-L1 upregulation in vascularized composite allotransplantation (VCA) grafts for immune tolerance. The research aims to advance understanding of mechanisms for improving immune tolerance in VCA transplants, which have potential applications for improving...
- Federal Project Grant Award Summary The Johns Hopkins University received a $487,765 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 30, 2025 through September 29, 2028. The award supports development of a novel digital twin technology designed to optimize normothermic vascularized composite allograft (VCA) preservation. This research initiative addresses critical advancement in organ and tissue...
- Federal Grant Award Summary The Johns Hopkins University received a $606,060 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 15, 2025 through July 14, 2027. The project, titled "Engineering Receptors to Promote Effective Infiltration of CAR T Cells into Bladder Tumors," supports advanced biomedical research aimed at developing innovative cancer immunotherapy approaches relevant to...
- The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
- This $867,712 Project Grant award from the Department of the Army Medical Command (under the Military Medical Research and Development program, CFDA 12.420) supports advanced biomedical research at The Johns Hopkins University focused on transforming healthcare for military service members and the general public. The research aims to investigate effective treatment of pancreatic cancer through systemic chemotherapy combined with alpha-particle radiotherapy, with a focus on early hepatic...
- Federal Grant Award Summary The Johns Hopkins University received a $318,483 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The award funds research titled "Quantitative Measurement of Acute and Chronic Lesion Activity in a Real-World Multisite Clinical MRI Dataset," which aims to develop quantitative methodologies for analyzing magnetic resonance imaging (MRI)...
- The Johns Hopkins University will receive $654,998 through a Project Grant award from the Defense Health Agency to support research targeting regulatory B cells to augment anti-bladder cancer immunity. The grant was awarded on June 1, 2023 under the Military Medical Research and Development program (CFDA 12.420), with work expected to be completed by May 31, 2026 in Baltimore, Maryland. Through this funding, The Johns Hopkins University will conduct research aimed at transforming healthcare...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a Project Grant totaling $776,831 under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award supports research on P2 purinergic receptors in pancreatic ductal adenocarcinoma as therapeutic targets, conducted at the institution's Baltimore, Maryland facility. This three-year research initiative represents DHA's investment...